Search

everythinglearnresearchcommunity

for

Search:↓

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Exposure to finasteride in the womb caused lasting reproductive issues in male rats.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

DHT, a testosterone byproduct, causes male pattern baldness.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Finasteride may cause kidney damage.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

Women with hyperandrogenism have higher androgen levels and lower SHBG, which may contribute to conditions like excessive hair growth and early puberty.

Carbamates may help treat androgen-dependent conditions by changing how certain lipid enzymes are produced.

Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.

Androstenedione is better than testosterone for diagnosing PCOS in Indian women.

The enzyme 5α-reductase is important for proper blood vessel development during the fertility-related transformation of the uterus lining.

Men with male-pattern baldness have higher levels of certain testosterone metabolites and may have more active androgen metabolism.

Finasteride affects frog testes by increasing testosterone, decreasing 5α-DHT, and impacting genes related to reproduction and other functions.

The developed model can predict effective 5-alpha-reductase enzyme inhibitors.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

The conclusion is that future hair loss treatments should target the root causes of hair thinning, not just promote hair growth.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

The seeds of Abrus precatorius, when processed, can prevent hair loss more effectively than common treatments.

Current research explores hair growth drugs, while future research aims for personalized treatments.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

The herbal extract was found to effectively reduce and prevent hair loss without any side effects.

The document concludes that protecting skin from the sun, avoiding smoking, and using treatments like Minoxidil and Finasteride can help manage skin and hair aging.

The combined herbal extracts improved hair regrowth in rats.

Low testosterone does not prevent prostate cancer in men with type 1 diabetes.

Certain gene variations are linked to a higher risk of severe acne, suggesting a genetic influence on the condition.

Women with PCOS have higher levels of certain androgens, which are good at predicting excess hair growth.

Testosterone affects androgen receptors and lipid storage in cells, while DHEA does not convert to testosterone or affect these receptors in the same way.